Northwest Biotherapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
18,499.00
14,255.00
22,699.00
6,871.00
117.00
22,224
Other Current Assets
147.00
387.00
1,402.00
1,013.00
1,285.00
1,574
Total Current Assets
18,646.00
14,642.00
24,101.00
7,884.00
1,402.00
23,798
Net Property, Plant & Equipment
83.00
39,999.00
46,157.00
44,874.00
47,488.00
108
Total Investments and Advances
-
1,760.00
349.00
-
-
-
Other Assets
55.00
2,040.00
190.00
148.00
17.00
761
Total Assets
18,784.00
58,441.00
70,797.00
52,906.00
48,907.00
24,677
ST Debt & Current Portion LT Debt
1,222.00
1,172.00
12,122.00
28,711.00
22,912.00
Accounts Payable
8,937.00
15,555.00
17,176.00
35,731.00
18,400.00
Other Current Liabilities
9,530.00
52,153.00
35,491.00
11,963.00
46,371.00
Total Current Liabilities
19,689.00
68,880.00
64,789.00
76,405.00
87,683.00
Long-Term Debt
-
24,490.00
10,543.00
3,000.00
8,517.00
Other Liabilities
-
98.00
141.00
-
-
Total Liabilities
19,689.00
93,468.00
75,473.00
79,405.00
96,200.00
Common Equity (Total)
9,818.00
35,027.00
4,676.00
26,499.00
67,333.00
Total Shareholders' Equity
9,818.00
35,027.00
4,676.00
26,499.00
47,293.00
Total Equity
9,818.00
35,027.00
4,676.00
26,499.00
47,293.00
Liabilities & Shareholders' Equity
18,784.00
58,441.00
70,797.00
52,906.00
48,907.00
Non-Equity Reserves
8,913.00
-
-
-
-
Preferred Stock (Carrying Value)
-
-
-
-
20,040.00
About Northwest Biotherapeutics
View Profile
